Unique ID issued by UMIN | UMIN000003974 |
---|---|
Receipt number | R000004791 |
Scientific Title | Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial (KABUTO-AF Trial) |
Date of disclosure of the study information | 2010/08/01 |
Last modified on | 2012/07/31 20:22:31 |
Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial (KABUTO-AF Trial)
Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial
(KABUTO-AF Trial)
Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial (KABUTO-AF Trial)
Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial
(KABUTO-AF Trial)
Japan |
Paroxysmal af with hypertension and implanted pacemakers
Cardiology |
Others
NO
The aim of the prospective study was to evaluate the anti-arrhythmic potential of selective aldosterone blocker (Eplerenone) in patients with paroxysmal Af using implanted device monitoring.
Efficacy
Percentage of documented Af burden (%)
Number of documented Af attack during 6 months
Progression to permanent Af
6-month major adverse cardiac and cerebral event (MACCE) rate
All cause death, cardiac death, myocardial infarction, PCI and/or CABG, Stroke, CHF requiring hospitalization,, aorta&peripheral artery disease, hemodialysis
CRP, WBC, fibrinogen, aldosterone, renin, BNP,
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
eplerenone 50-100mg for 6-month
conventional medication without eplerenone for 6-month
20 | years-old | <= |
90 | years-old | >= |
Male and Female
DDD pacemaker(Device implantation>210 days)
Documented paroxysmal Af
Af burden(>2% &<90%)
High BP(130-139/85-89mmHg)and Hypertension(140=or</90=or< mmHg)
Age>20-90years
Written informed consent
Previous administration of eplerenone
Low EF<40%
Symptomatic heart failure (NYHA>II)
Enlarged LAD>55mm
Valvular disease requiring surgical
operation
chronic Af
ACS<30 days
Cardiogenic shock
Contraindication for Eplerenone
Intolerance to Eplerenone
Scheduled Cardiac surgery within 1year
Scheduled Catheter ablation within 1 year
Symptomatic arterial hypotension
Secondary hypertension
ICD
pacemaker program change for af suppression options
pregnancy
Chronic inflammatory disease
Malignancy
Severe infection
Life expectancy<1years
eGFR<40
Dialysis
Severe Liver dysfunction
Drug addiction
Alcohol abuse
Inability to give informed consent
100
1st name | |
Middle name | |
Last name | Hiroaki Matsubara, Takeshi Shirayama |
KPUM KABUTO-AF study investigators
Kyoto Prefectural University of Medicine(KPUM),Dept of Cardiology
465 Kajii-cho Kawaramachi-dori Hirokoji Kamigyo-ku Kyoto Japan 602-8566
075-251-5511
1st name | |
Middle name | |
Last name | Hiroaki Matsubara, Takeshi Shirayama |
KPUM KABUTO-AF study investigators
Kyoto Prefectural University of Medicine(KPUM), Dept of Cardiology
465 Kajii-cho Kawaramachi-dori Hirokoji Kamigyo-ku Kyoto Japan 602-8566
075-251-5511
sirayama@koto.kpu-m.ac.jp
KPUM KABUTO-AF study investigators
Kyoto Prefectural University of Medicine
Self funding
Japan
NO
京都府立医科大学 (京都府)
2010 | Year | 08 | Month | 01 | Day |
Unpublished
Completed
2010 | Year | 04 | Month | 30 | Day |
2010 | Year | 07 | Month | 01 | Day |
2012 | Year | 03 | Month | 31 | Day |
2012 | Year | 03 | Month | 31 | Day |
2012 | Year | 03 | Month | 31 | Day |
2012 | Year | 04 | Month | 30 | Day |
2010 | Year | 07 | Month | 31 | Day |
2012 | Year | 07 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004791